author-photo

Yanyan Jiang

University of Oxford

32

Papers

787

Citations

Citation Trend

Filter By

Papers (23) Sort By

Journal Conference Others

Germline and somatic genetic variants in the p53 pathway interact to affect cancer risk, progression, and drug response.

2021 Cancer Research
Show All
- Source
- Cite
- Save
Citations (7)
DNAPK inhibition preferentially compromises the repair of radiation-induced DNA double-strand breaks in chronically hypoxic tumor cells in xenograft models

2021 Molecular Cancer Therapeutics
Show All
- Source
- Cite
- Save
Citations (2)
CHK1 inhibition exacerbates replication stress induced by IGF blockade

2021 Oncogene
Show All
- Source
- Cite
- Save
Citations (0)
Overcoming acquired resistance to HSP90 inhibition by targeting JAK-STAT signalling in triple-negative breast cancer

2019 BMC Cancer
Show All
- Source
- Cite
- Save
Citations (17)
Germline and somatic genetic variants in the p53 pathway interact to affect cancer risk, progression and drug response

2019 bioRxiv
Show All
- Source
- Cite
- Save
Citations (5)
RASSF1A controls tissue stiffness and cancer stem‐like cells in lung adenocarcinoma

2019 The EMBO Journal
Show All
- Source
- Cite
- Save
Citations (31)
Hippo Pathway Deregulation Drives Tissue Stiffness and Cancer Stem-like Cells in Lung Adenocarcinoma

2018 bioRxiv
Show All
- Source
- Cite
- Save
Citations (1)
Abstract B40: WEE1 inhibition selectively kills histone H3K36me3-deficient cancers by dNTP starvation

2016 Cancer Research
Show All
- Source
- Cite
- Save
Citations (0)
Inhibiting WEE1 Selectively Kills Histone H3K36me3-Deficient Cancers by dNTP Starvation

2015 Cancer Cell
Show All
- Source
- Cite
- Save
Citations (186)
Abstract B88: Mechanisms of resistance to the Hsp90 inhibitor ganetespib in triple negative breast cancer

2015 Molecular Cancer Therapeutics
Show All
- Source
- Cite
- Save
Citations (0)